| Trial ID: | L1467 |
| Source ID: | NCT05817799
|
| Associated Drug: |
L-Carnitine 500mg Thrice Daily
|
| Title: |
Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hemodialysis Complication
|
| Interventions: |
DRUG: L-Carnitine 500Mg thrice daily|DRUG: 1g L-Carnitine IV three times a week
|
| Outcome Measures: |
Primary: L-Carnitine levels in hemodialysis, plasma carnitine will be detected before and after giving intervention (unit μmol/L), 5 months |
|
| Sponsor/Collaborators: |
Sponsor: Bahria University | Collaborators: Pakistan Navy Station Shifa Hospital|Jinnah Postgraduate Medical Centre|University of Karachi
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
83
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
|
| Start Date: |
2023-01-01
|
| Completion Date: |
2023-07-10
|
| Results First Posted: |
|
| Last Update Posted: |
2024-08-09
|
| Locations: |
Jinnah Post Graduate Medical Center, Karachi, Sindh, 021, Pakistan
|
| URL: |
https://clinicaltrials.gov/show/NCT05817799
|
